Index of reports
> Life Threatening Events (13)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kayexalate (Sodium Polystyrene Sulfonate) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-08
Patient: 56 year old male, weighing 92.0 kg (202.4 pounds)
Reactions: Condition Aggravated, Cardiomyopathy, Bladder Cancer, Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Aspirin
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Diamicron
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Bisoprolol Fumarate
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Perindopril Erbumine
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Actos
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Prazosin HCL
Indication: Hypertension
End date: 2010-02-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29
Patient: 56 year old male, weighing 92.0 kg (202.4 pounds)
Reactions: Bladder Cancer
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Diamicron
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Bisoprolol Fumarate
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Aspirin
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Prazosin HCL
Indication: Hypertension
End date: 2010-02-01
Actos
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Perindopril Erbumine
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-19
Patient: 56 year old male
Reactions: Bladder Transitional Cell Carcinoma Stage II, Cardiomyopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Diamicron (Gliclazide)
Dosage: 30 mg, qd, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Perindopril Erbumine
Dosage: 2.5 mg
Start date: 2009-12-01
Aceon
Dosage: 2.5 mg,qd,oral
Administration route: Oral
Bisoprolol Fumarate
Dosage: 2.5 mg, qd, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Allopurinol
Dosage: 300 mg, qd, oral
Administration route: Oral
Indication: Hyperuricaemia
Fenofibrate
Dosage: 200 mg, qd, oral
Administration route: Oral
Indication: Hypertriglyceridaemia
Januvia
Dosage: 100 mg, qd, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Kayexalate
Dosage: 1 unit every 2 weeks, oral
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Aspirin
Dosage: 75 mg, qd, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Actos
Dosage: 30 mg, qd, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Minirin
Dosage: 100 ug, tid, oral
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Prazosin HCL
Dosage: 5 mg, qd, oral
Administration route: Oral
Indication: Hypertension
End date: 2010-02-01
Possible Kayexalate side effects in 56 year old male
Reported by a individual with unspecified qualification from France on 2012-03-13
Patient: 56 year old male
Reactions: Condition Aggravated, Cardiomyopathy, Bladder Transitional Cell Carcinoma Stage II, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Fenofibrate
Dosage: 200 mg, before 2006, oral
Administration route: Oral
Indication: Hypertriglyceridaemia
Start date: 2006-01-01
Diamicron (Gliclazide) Tablet 30 MG
Dosage: 30 mg, before 2006, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-01-01
Allopurinol
Dosage: 300 mg, before 2006, oral
Administration route: Oral
Indication: Hyperuricaemia
Start date: 2006-01-01
Januvia
Dosage: 100 mg, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Actos
Dosage: 30 mg, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Perindopril Erbumine
Dosage: 2.5 mg, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Aspirin
Dosage: 75 mg, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Bisoprolol Fumarate
Dosage: 2.5 mg, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Desmopressin Acetate
Dosage: 300 ug, oral
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Prazosin HCL
Dosage: oral
Administration route: Oral
Indication: Hypertension
Start date: 2006-01-01
End date: 2010-02-01
Kayexalate
Dosage: oral
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Possible Kayexalate side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-09
Patient: male
Reactions: Type 2 Diabetes Mellitus, Bladder Cancer Stage II, Cardiac Failure, Congestive Cardiomyopathy, Cardiomyopathy, Appendicitis, Hyperuricaemia, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Actos
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Aspirin
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Prazosin HCL
Administration route: Oral
Indication: Hypertension
End date: 2010-02-01
Diamicron
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2010-03-30
Prazosin HCL
Indication: Congestive Cardiomyopathy
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Perindopril Erbumine
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Kayexalate
Indication: Congestive Cardiomyopathy
Bisoprolol Fumarate
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Other drugs received by patient: Metformin HCL; Victoza
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07
Patient: 56 year old male
Reactions: Bladder Transitional Cell Carcinoma Stage II
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Actos
Administration route: Oral
Start date: 2006-03-01
End date: 2010-02-01
Diamicron
Administration route: Oral
Metformin HCL
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Januvia
Administration route: Oral
Start date: 2009-10-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Perindopril Erbumine
Administration route: Oral
Start date: 2009-12-01
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Bisoprolol Fumarate
Administration route: Oral
Start date: 2009-12-01
Aspirin
Administration route: Oral
Start date: 2009-12-01
Prazosin HCL
Administration route: Oral
End date: 2010-02-01
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-02
Patient: 56 year old male
Reactions: Bladder Transitional Cell Carcinoma Stage II
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prazosin HCL
Dosage: 5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
End date: 2010-02-01
Bisoprolol Fumarate
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Januvia
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Diamicron
Dosage: 30 mg, 1x/day
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Perindopril Erbumine
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Aspirin
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Kayexalate
Dosage: 1 df, 2x/week
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Minirin
Dosage: 100 ug, 3x/day
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Actos
Dosage: 30 mg, 1x/day
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Fenofibrate
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Hypertriglyceridaemia
Allopurinol
Dosage: 300 mg, 1x/day
Administration route: Oral
Indication: Hyperuricaemia
Possible Kayexalate side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-02
Patient: male
Reactions: Bladder Cancer Stage II, Cardiac Failure, Cardiomyopathy, Appendicitis, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Diamicron
Administration route: Oral
Indication: Pain
End date: 2010-03-30
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Actos
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Perindopril Erbumine
Dosage: 100 mcg thrice
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 1999-12-01
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Prazosin HCL
Administration route: Oral
Indication: Hypertension
End date: 2010-02-01
Bisoprolol Fumarate
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Aspirin
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 1999-12-01
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Other drugs received by patient: Victoza; Metformin HCL
Possible Kayexalate side effects in 93 year old female
Reported by a physician from Japan on 2011-12-01
Patient: 93 year old female
Reactions: Urinary Tract Infection, Pseudomembranous Colitis, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kayexalate
Administration route: Oral
Start date: 2011-06-06
End date: 2011-07-09
Lasix
Administration route: Oral
Start date: 2011-06-06
End date: 2011-07-09
Other drugs received by patient: Allopurinol; ALL Other Therapeutic Products; Erispan; Amlodipine; Atorvastatin
Possible Kayexalate side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-01
Patient: 69 year old female, weighing 69.5 kg (152.9 pounds)
Reactions: Rhabdomyolysis, Renal Failure Acute, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Kayexalate
Other drugs received by patient: Insulatard NPH Human; Irbesartan; Sectral; Atorvastatin Calcium; Depakote; Acarbose; Imovane
Possible Kayexalate side effects in 45 year old male
Reported by a physician from Japan on 2011-10-24
Patient: 45 year old male, weighing 52.0 kg (114.4 pounds)
Reactions: Interstitial Lung Disease
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Allopurinol
Dosage: daily dose 100 mg
Administration route: Oral
Indication: Hyperuricaemia
Calcium Carbonate
Dosage: daily dose 3000 mg
Administration route: Oral
Indication: Hyperphosphataemia
Kayexalate
Dosage: daily dose 15 g
Administration route: Oral
Indication: Hyperkalaemia
Cinacalcet Hydrochloride
Dosage: daily dose 25 mg
Administration route: Oral
Indication: Hyperparathyroidism Secondary
Sevelamer Hydrochloride
Dosage: daily dose 2250 mg
Administration route: Oral
Indication: Hyperphosphataemia
Nexavar
Dosage: 200 mg, qd
Administration route: Oral
Indication: Renal Cell Carcinoma
Start date: 2011-05-12
End date: 2011-05-15
Ticlopidine HCL
Dosage: daily dose 200 mg
Administration route: Oral
Zantac
Dosage: daily dose 300 mg
Administration route: Oral
Indication: Gastritis
Possible Kayexalate side effects in 79 year old male
Reported by a physician from Japan on 2011-10-18
Patient: 79 year old male, weighing 51.0 kg (112.2 pounds)
Reactions: Bradycardia, Constipation, Hypokalaemia, Myopathy
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Kayexalate
Other drugs received by patient: Paxil; Acetanol; Magnesium Sulfate; Daikentyuto; Ferrous Sulfate TAB; Calcium Polystyrene Sulfonate; Aspirin; Captopril; Dogmatyl; Adalat; Juzentaihoto
Possible Kayexalate side effects in 93 year old female
Reported by a physician from Japan on 2011-10-10
Patient: 93 year old female
Reactions: Haemoglobin Decreased, Urinary Tract Infection, Pseudomembranous Colitis, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lasix
Administration route: Oral
Start date: 2011-06-06
End date: 2011-07-07
Kayexalate
Administration route: Oral
Start date: 2011-06-06
End date: 2011-07-07
Other drugs received by patient: Allopurinol; ALL Other Therapeutic Products; Amlodipine; Erispan; Atorvastatin
|